P. Cheema

Type de document

Co-auteur

M. Yan

M. Yamaguchi

J. Wang

D. Voong

D.S. Shames

S.M. Shagan

E. Schleifman

T. Riehl

S. Peters

S. Novello

A. Morabito

T. Mok

S. Mocci

M.S. Mathisen

M. Johnson

D.R. Gandara

S.M. Gadgeel

E. Felip

D.A. Fabrizio

R. Dziadziuszko

E. Dansin

P. Danchaivijitr

M. Cobo

C.H. Barrios

Z. Andric

Source

Serveur académique Lausannois (1)

Mot-clé

thérapie (1) norme (1) sécurité (1) intérêts (1) analyse (1) danger (1) exploration (1) analyse (1) biomarqueur (1) procès (1) cancer (1) survie (1) Treatment (1) Chemotherapy (1) Cancer (1) Care (1) Therapeutics (1) Theater (1) Survival (1) Population (1) Patients (1) Manufacturers' agents (1) Human beings (1) Lungs--Cancer (1) Lungs (1) Interest (1) Immunotherapy (1) Drama (1) Confidence (1) Commission merchants (1)

Documents écrit par P. Cheema (1) | parle de P. Cheema (0)

Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial.

S. Peters et al.